Literature DB >> 16511266

The production, purification and crystallization of a soluble form of the nonclassical MHC HLA-G: the essential role of cobalt.

Craig S Clements1, Lars Kjer-Nielsen, Lyudmila Kostenko, James McCluskey, Jamie Rossjohn.   

Abstract

HLA-G is a nonclassical class I major histocompatibility complex (MHC) molecule that is primarily expressed at the foetal-maternal interface. Although the role of HLA-G has not been fully elucidated, current evidence suggests it protects the foetus from the maternal immune response. In this report, HLA-G (44 kDa) is characterized by expression in Escherichia coli. The inclusion bodies were refolded in complex with a peptide derived from histone H2A (RIIPRHLQL), purified and subsequently crystallized. Correct refolding was determined using two conformation-dependent antibodies. Cobalt ions were shown to be an essential ingredient for obtaining diffraction-quality crystals. The crystals, which diffracted to 1.9 A resolution, belonged to space group P3(2)2(1), with unit-cell parameters a = b = 77.15, c = 151.72 A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511266      PMCID: PMC2150919          DOI: 10.1107/S1744309105041473

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  27 in total

1.  The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

Authors:  T L Chapman; A P Heikeman; P J Bjorkman
Journal:  Immunity       Date:  1999-11       Impact factor: 31.745

Review 2.  HLA-G remains a mystery.

Authors:  D Bainbridge; S Ellis; P Le Bouteiller; I Sargent
Journal:  Trends Immunol       Date:  2001-10       Impact factor: 16.687

3.  The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Andrew G Brooks; Anthony W Purcell; Marcos R Fontes; James McCluskey; Jamie Rossjohn
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

4.  Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition.

Authors:  Akiko Ishitani; Noriko Sageshima; Ni Lee; Natalia Dorofeeva; Katsuhiko Hatake; Hans Marquardt; Daniel E Geraghty
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

5.  Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens.

Authors:  A Ishitani; D E Geraghty
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state.

Authors:  Craig S Clements; Lars Kjer-Nielsen; Whitney A MacDonald; Andrew G Brooks; Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-11-23

7.  Disulfide bond-mediated dimerization of HLA-G on the cell surface.

Authors:  Jonathan E Boyson; Robert Erskine; Mary C Whitman; Michael Chiu; Julie M Lau; Louise A Koopman; Markus M Valter; Pavla Angelisova; Vaclav Horejsi; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-26       Impact factor: 11.205

8.  Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.

Authors:  Mitsunori Shiroishi; Kouhei Tsumoto; Kimie Amano; Yasuo Shirakihara; Marco Colonna; Veronique M Braud; David S J Allan; Azure Makadzange; Sarah Rowland-Jones; Benjamin Willcox; E Yvonne Jones; P Anton van der Merwe; Izumi Kumagai; Katsumi Maenaka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

Review 9.  Tetrameric complexes of HLA-E, HLA-F, and HLA-G.

Authors:  David S J Allan; Eric J M Lepin; Veronique M Braud; Christopher A O'Callaghan; Andrew J McMichael
Journal:  J Immunol Methods       Date:  2002-10-01       Impact factor: 2.303

10.  IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex.

Authors:  James Robinson; Matthew J Waller; Peter Parham; Natasja de Groot; Ronald Bontrop; Lorna J Kennedy; Peter Stoehr; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

View more
  4 in total

1.  The structure of the cytomegalovirus-encoded m04 glycoprotein, a prototypical member of the m02 family of immunoevasins.

Authors:  Richard Berry; Julian P Vivian; Felix A Deuss; Gautham R Balaji; Philippa M Saunders; Jie Lin; Dene R Littler; Andrew G Brooks; Jamie Rossjohn
Journal:  J Biol Chem       Date:  2014-06-30       Impact factor: 5.157

2.  The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4.

Authors:  Shoeib Moradi; Richard Berry; Phillip Pymm; Corinne Hitchen; Simone A Beckham; Matthew C J Wilce; Nicholas G Walpole; Craig S Clements; Hugh H Reid; Matthew A Perugini; Andrew G Brooks; Jamie Rossjohn; Julian P Vivian
Journal:  J Biol Chem       Date:  2015-03-10       Impact factor: 5.157

3.  The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide.

Authors:  Nicholas G Walpole; Lars Kjer-Nielsen; Lyudmila Kostenko; James McCluskey; Andrew G Brooks; Jamie Rossjohn; Craig S Clements
Journal:  J Mol Biol       Date:  2010-02-01       Impact factor: 5.469

4.  Targeting of a natural killer cell receptor family by a viral immunoevasin.

Authors:  Richard Berry; Natasha Ng; Philippa M Saunders; Julian P Vivian; Jie Lin; Felix A Deuss; Alexandra J Corbett; Catherine A Forbes; Jacqueline M Widjaja; Lucy C Sullivan; Adrian D McAlister; Matthew A Perugini; Melissa J Call; Anthony A Scalzo; Mariapia A Degli-Esposti; Jerome D Coudert; Travis Beddoe; Andrew G Brooks; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2013-05-12       Impact factor: 25.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.